Contrast agents for applications including perfusion imaging

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9408927
APP PUB NO 20110091374A1
SERIAL NO

12919600

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed, in part, to compounds and methods for imaging the central nervous system or cancer, comprising administering to a subject a contrast agent which comprises a compound that binds MC-I, and an imaging moiety, and scanning the subject using diagnostic imaging.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LANTHEUS MEDICAL IMAGING INC331 TREBLE COVE ROAD NORTH BILLERICA MA 01862

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Casebier, David S Carlisle, US 40 527
Kagan, Mikhail North Chelmsford, US 3 166
Lazewatsky, Joel Auburndale, US 13 184
Robinson, Simon P Stow, US 53 638
Yu, Ming Chelmsford, US 188 1569

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 9, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00